The childhood AML studies BFM-78 and -83: treatment results and risk factor analysis

Haematol Blood Transfus. 1987:30:71-5. doi: 10.1007/978-3-642-71213-5_12.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Child
  • Clinical Trials as Topic
  • Cyclophosphamide / administration & dosage
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Germany, West
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Methotrexate / administration & dosage
  • Prednisone / administration & dosage
  • Prognosis
  • Remission Induction
  • Risk
  • Thioguanine / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Cytarabine
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Thioguanine
  • Prednisone
  • Methotrexate
  • Daunorubicin

Supplementary concepts

  • BFM 78 protocol